Tyler B Jensen, PhD
About
Copy Link
Biography
Tyler is an eighth year MD/PhD student in the MSTP program and postdoctoral associate in the lab of Dr. Berna Sozen. He performed his PhD in the Genetics Department co-mentored by Dr. Siyuan Wang and Dr. Andrew Xiao (2020-2024). Tyler earned his bachelor’s degree in biochemistry from Northeastern University in 2017. During his undergraduate studies, he interned at Tetraphase Pharmaceuticals in 2014 working on tetracycline antibiotic development, and Epizyme Inc. in 2015, working on developing small molecule epigenetic inhibitors for molecularly defined cancers. In addition to his internships, Tyler worked in the lab of Dr. James Monaghan studying axolotls, working to understand the nervous system’s role in tissue regeneration. He is now studying chromatin biology during early embryonic development and helping build models of human embryogenesis. Tyler has been awarded the Ruth L. Kirschstein National Research Service Award (NRSA) F30 for his work on histone variants in human embryonic development through the National Institute of Child Health and Human Development (NICHD). His recent work has identified the critical role of the histone H2A variant H2A.J in human trophoblast and embryonic progression. By understanding how the earliest stem cells organize their genome during development, we can identify governing principles of cell fate determination, and how to better help patients with recurrent pregnancy loss.
Education & Training
- PhD
- Yale University, Genetics (2024)
- BS
- Northeastern University, Biochemistry (2017)
Research
Copy Link
Overview
Medical Research Interests
ORCID
0000-0003-0220-4026
Research at a Glance
Yale Co-Authors
Publications Timeline
Research Interests
Siyuan (Steven) Wang, PhD
Berna Sozen, PhD
Fangyong Li, MS, MPH
Jeffrey Townsend, PhD
Jenna Bergmann
Liangwen Zhong, PhD
Chromatin
Publications
2025
Epigenetic priming promotes tyrosine kinase inhibitor resistance and oncogene amplification.
Starble RM, Sun EG, Gbyli R, Radda J, Lu J, Jensen TB, Sun N, Khudaverdyan N, Zhao T, Hu B, Melnick MA, Zhao S, Roper N, Wang GG, Tackett AJ, Wang Y, Song J, Politi K, Wang S, Xiao AZ. Epigenetic priming promotes tyrosine kinase inhibitor resistance and oncogene amplification. Nat Struct Mol Biol 2025 PMID: 41131337, DOI: 10.1038/s41594-025-01685-4.Peer-Reviewed Original ResearchTracing the evolution of single-cell 3D genomes in Kras-driven cancers
Liu M, Jin S, Agabiti S, Jensen T, Yang T, Radda J, Ruiz C, Baldissera G, Rajaei M, Li F, Townsend J, Muzumdar M, Wang S. Tracing the evolution of single-cell 3D genomes in Kras-driven cancers. Nature Genetics 2025, 1-13. PMID: 40825871, DOI: 10.1038/s41588-025-02297-w.Peer-Reviewed Original ResearchCitationsAltmetricConceptsCell-to-cell heterogeneityGenome-wide chromatinGenome compactionGenome architectureGenomic structureGenome mappingGenome regulationLung adenocarcinomaDependent genesKRAS-driven cancersGenomeMouse lung adenocarcinomaCancer progressionEarly tumor progressionSingle cellsCancer stateGenesPancreatic ductal adenocarcinomaInvasive tumorsTherapeutic biomarkersDuctal adenocarcinomaTumor progressionCompartmental changesChromatinCancerPerturb-tracing enables high-content screening of multi-scale 3D genome regulators
Cheng Y, Hu M, Yang B, Jensen T, Zhang Y, Yang T, Yu R, Ma Z, Radda J, Jin S, Zang C, Wang S. Perturb-tracing enables high-content screening of multi-scale 3D genome regulators. Nature Methods 2025, 22: 950-961. PMID: 40211002, PMCID: PMC12074983, DOI: 10.1038/s41592-025-02652-z.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsLoss-of-function screensPooled CRISPR screensIdentified new regulatorsGenome organizationChromatin domainsGenome regulationChromatin organizationChromosome territoriesChromatin tracingChromatin foldingChromatin topologyCRISPR screensHigh-content screeningChromatin compactionNuclear architectureLoop extrusionChromatinGenomic mechanismsHigh-content screening platformHuman cellsCompartmentalization mechanismFunctional linkTopological regulationGenomic effectsScreening platform
2024
Selective utilization of glucose metabolism guides mammalian gastrulation
Cao D, Bergmann J, Zhong L, Hemalatha A, Dingare C, Jensen T, Cox A, Greco V, Steventon B, Sozen B. Selective utilization of glucose metabolism guides mammalian gastrulation. Nature 2024, 634: 919-928. PMID: 39415005, PMCID: PMC11499262, DOI: 10.1038/s41586-024-08044-1.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCellular metabolismMammalian gastrulationHexosamine biosynthetic pathwayTranscription factor networksCellular signaling pathwaysSignaling morphogensGlucose metabolismCellular programmeBiosynthetic pathwayFate acquisitionCell fateHousekeeping natureGenetic mechanismsMesoderm migrationFactor networksERK activationExpression patternsSignaling pathwayDevelopmental processesStem cell modelCell typesSpecialized functionsDevelopmental contextMammalian embryosMouse embryos
2021
Lung injury in axolotl salamanders induces an organ‐wide proliferation response
Jensen TB, Giunta P, Schultz NG, Griffiths JM, Duerr TJ, Kyeremateng Y, Wong H, Adesina A, Monaghan JR. Lung injury in axolotl salamanders induces an organ‐wide proliferation response. Developmental Dynamics 2021, 250: 866-879. PMID: 33587313, DOI: 10.1002/dvdy.315.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsLung regenerationLung massX cranial nervesLung injurySupplemental administrationCranial nervesProliferative responseProliferation responseInjury responseLungInjuryMultiple cell typesMesenchymal cellsNeuregulinAmputationMost tissuesPneumocytesProliferationCell typesResponseAxolotl salamanderCellsNerve
2017
Transcriptional correlates of proximal-distal identify and regeneration timing in axolotl limbs
Voss S, Murrugarra D, Jensen TB, Monaghan JR. Transcriptional correlates of proximal-distal identify and regeneration timing in axolotl limbs. Comparative Biochemistry And Physiology Part C Toxicology & Pharmacology 2017, 208: 53-63. PMID: 29107037, PMCID: PMC5920805, DOI: 10.1016/j.cbpc.2017.10.010.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsAxolotl limbsDynamic transcriptional regulationSimilar transcriptional patternsCell cycle transcriptsDifferentiated muscle cellsProximal-distal limb axisExtracellular matrix moleculesMemory genesTranscriptional regulationTranscript abundanceTranscriptional patternsExpression patternsLimb regenerationGene expressionBlastema cellsPositional memoryArm cellsCell adhesionGenesMatrix moleculesCell surfaceEpithelial proteinsPositional informationTissue remodelingTranscriptional correlates
2015
Exploring drug delivery for the DOT1L inhibitor pinometostat (EPZ-5676): Subcutaneous administration as an alternative to continuous IV infusion, in the pursuit of an epigenetic target
Waters NJ, Daigle SR, Rehlaender BN, Basavapathruni A, Campbell CT, Jensen TB, Truitt BF, Olhava EJ, Pollock RM, Stickland KA, Dovletoglou A. Exploring drug delivery for the DOT1L inhibitor pinometostat (EPZ-5676): Subcutaneous administration as an alternative to continuous IV infusion, in the pursuit of an epigenetic target. Journal Of Controlled Release 2015, 220: 758-765. PMID: 26385168, DOI: 10.1016/j.jconrel.2015.09.023.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsMeSH KeywordsAdministration, OralAnimalsAntineoplastic AgentsBenzimidazolesBiological AvailabilityChemistry, PharmaceuticalDelayed-Action PreparationsDNA MethylationDogsDrug Administration ScheduleDrug CarriersEnzyme InhibitorsEpigenesis, GeneticGene Expression Regulation, LeukemicHistone-Lysine N-MethyltransferaseHumansInfusions, IntravenousInjections, SubcutaneousLeukemia, Biphenotypic, AcuteMaleMethyltransferasesMiceRats, Sprague-DawleyTumor BurdenXenograft Model Antitumor AssaysConceptsXenograft modelRefractory acute leukemia patientsFurther evaluationPhase 1 clinical trialSubcutaneous bolus administrationAcute leukemia patientsTumor growth inhibitionDOT1L inhibitor pinometostatExtended-release formulationRat xenograft modelMLL-r leukemiaThrice dailyPharmacodynamic markersSC administrationBolus administrationClinical trialsSubcutaneous administrationComplete bioavailabilityDOT1L activityLeukemia patientsOral administrationPatient conveniencePreclinical studiesSmall molecule inhibitorsImproved exposure
Get In Touch
Copy Link